-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G5QTWiRbpr6s+rpMY7gFZB3OG3ayjGfdff2XQ9OVLBnObpkCVHg9yWmwjNurQrc7 z6mEH31K3uueC/uKW7RhrA== 0000891836-07-000333.txt : 20071113 0000891836-07-000333.hdr.sgml : 20071112 20071113111927 ACCESSION NUMBER: 0000891836-07-000333 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20071113 DATE AS OF CHANGE: 20071113 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDQUIST INC CENTRAL INDEX KEY: 0000884497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 222531298 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-42936 FILM NUMBER: 071235669 BUSINESS ADDRESS: STREET 1: 1000 BISHOPS GATE BLVD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054-4632 BUSINESS PHONE: 8568108000 MAIL ADDRESS: STREET 1: 1000 BISHOPS GATE BLVD STREET 2: SUITE 300 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054-4632 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KONINKLIJKE PHILIPS ELECTRONICS NV CENTRAL INDEX KEY: 0000313216 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC BUSINESS PHONE: 31 20 59 77777 MAIL ADDRESS: STREET 1: BREITNER CENTER STREET 2: AMSTELPLEIN 2 CITY: AMSTERDAM STATE: P7 ZIP: 1096 BC FORMER COMPANY: FORMER CONFORMED NAME: PHILIPS ELECTRONICS N V DATE OF NAME CHANGE: 19930727 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPS NV DATE OF NAME CHANGE: 19910903 SC 13D/A 1 sc0145.txt AMENDMENT NO. 6 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 6) MedQuist Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, No Par Value - -------------------------------------------------------------------------------- (Title of Class of Securities) 584949101 - -------------------------------------------------------------------------------- (CUSIP Number) Neil T. Anderson, Esq. Sullivan & Cromwell LLP 125 Broad Street New York, New York 10004-2498 (212) 558-4000 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 8, 2007 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If a filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d- 1(g), check the following box [ ]. - -------------------------------------------------------------------------------- CUSIP NO. 584949101 - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON Koninklijke Philips Electronics N.V. I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 222531298 - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [_] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. SOURCE OF FUNDS OO - -------------------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [_] - -------------------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION The Netherlands - -------------------------------------------------------------------------------- 7. SOLE VOTING POWER NUMBER OF 26,085,086 SHARES -------------------------------------------------------------- BENEFICIALLY 8. SHARED VOTING POWER OWNED BY 0 EACH -------------------------------------------------------------- REPORTING 9. SOLE DISPOSITIVE POWER PERSON 26,085,086 WITH -------------------------------------------------------------- 10. SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 26,085,086 - -------------------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [_] - -------------------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 69.6% - -------------------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON CO - -------------------------------------------------------------------------------- -2- Item 1. Security and Issuer. This Amendment No. 6 relates to the common stock, no par value (the "Shares") of MedQuist Inc., a New Jersey corporation ("MedQuist"). This Amendment No. 6 amends and supplements Item 6 and Item 7 of the Statement on Schedule 13D dated June 6, 2000 (the "Schedule 13D") filed by Koninklijke Philips Electronics N.V., a corporation incorporated under the laws of The Netherlands ("Philips"), as previously amended and supplemented by Amendment No. 1 to the Schedule 13D, dated July 28, 2000, Amendment No. 2 to the Schedule 13D, dated August 2, 2000, Amendment No. 3 to the Schedule 13D, dated August 24, 2000, Amendment No. 4 to the Schedule 13D, dated July 6, 2007 and Amendment No. 5 to the Schedule 13D, dated November 2, 2007. Unless otherwise defined herein, all capitalized terms used herein shall have the meanings ascribed to them in the Schedule 13D. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. On November 8, 2007, MedQuist and Philips entered into an amendment (the "Amendment") of the Governance Agreement by and between MedQuist and Philips dated May 22, 2000 (the "Governance Agreement"). The Supervisory Committee of the Board of Directors of MedQuist (the "Board"), responsible for, among other things, the general oversight, administration, amendment and enforcement of all material agreements or arrangements between MedQuist and Philips, approved the Amendment. The Amendment establishes the composition of the Board in the event the number of directors constituting the whole Board is set at seven (its current size). It also provides for vacancies in Board seats held by Independent Directors (as defined in the Governance Agreement) to be filled by an affirmative vote of the remaining directors in the event there are no Independent Directors on the Board. A complete copy of the Amendment is attached to this report as Exhibit 1 and is incorporated herein by reference. Item 7. Material to be Filed as Exhibits Exhibit Description ------- ----------- 1 Amendment, dated November 8, 2007, to the Governance Agreement, dated May 22, 2000, between Philips and MedQuist. -3- SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: November 13, 2007 KONINKLIJKE PHILIPS ELECTRONICS N.V. By: /s/ P.J. SIVIGNON ---------------------------------------- Name: P.J. Sivignon Title: Executive Vice President & CFO By: /s/ E.P. COUTINHO ---------------------------------------- Name: E.P. Coutinho Title: General Secretary and Chief Legal Officer -4- EX-99.1 2 exhibit_1.txt AMENDMENT TO GOVERNANCE AGMT Exhibit 1 November 8, 2007 Koninklijke Philips Electronics N.V. Rembrandt Tower Amstelplein 1 1096 HA Amsterdam, The Netherlands Re: Amendment to the Governance Agreement by and between Koninklijke Philips Electronics N.V. ("Purchaser") and MedQuist Inc. (the "Company") dated May 22, 2000 (the "Governance Agreement") Ladies and Gentleman: This letter constitutes an amendment to the Governance Agreement. The Governance Agreement shall be amended as follows: o A new Section 3.01(g) is hereby added to the Governance Agreement to read as follows: If the number of directors constituting the whole Board of Directors shall be fixed at seven directors and Purchaser and its Subsidiaries shall beneficially own, in the aggregate, at least a majority of the outstanding Voting Stock, the Board of Directors shall consist of four Purchaser Directors and three Independent Directors. o A new sentence is added to the end of Section 3.4(a) to read as follows: Notwithstanding anything in this Agreement to the contrary, in the event that at any time there shall be no Independent Directors on the Board of Directors, whether by reason of death, resignation, retirement, disqualification, removal from office or other causes, such vacancies shall be filled by an affirmative vote of the remaining directors as provided in the by-laws. Except as amended hereby, all of the terms and provisions of the Governance Agreement shall remain in full force and effect. Please indicate your agreement with the above amendment by signing where indicated below and returning one copy of this letter amendment to MedQuist Inc., 1000 Bishops Gate Blvd., Suite 300, Mt. Laurel, New Jersey 08054, USA, Attention: General Counsel. All capitalized terms not defined herein shall have the same meanings as given to them in the Governance Agreement. Pursuant to the terms of the Governance Agreement, this letter amendment has been approved by the Supervisory Committee and will be effective as of the date it is executed by Purchaser as indicated below. Sincerely, MedQuist Inc. By: /s/ Howard S. Hoffmann ----------------------------------- Howard S. Hoffmann, CEO & President Agreed by: Koninklijke Philips Electronics N.V. By: /s/ Stephen H. Rusckowski - ------------------------------------ Stephen H. Rusckowski Member, Royal Philips Board of Management (Medical Systems) Date: November 8, 2007 -----END PRIVACY-ENHANCED MESSAGE-----